Post-COVID: Improvement in Symptoms Does Not Mean Full Recovery

How does post-COVID syndrome develop over time? This was the question addressed by the PCS-Journey research project (“Unraveling the Post COVID Syndrome Journey”), led by Dr Dominik Schröder. Schröder is a research associate at the Department of General Practice at University Medical Center Göttingen.

The PCS-Journey project is part of the LongCARE platform, which is funded by the German Federal Ministry of Health and coordinated by TMF – Technology, Methods, and Infrastructure for Networked Medical Research (TMF e.V.). The platform brings together research activities investigating the long-term effects of COVID-19, with a focus on translating scientific findings into practice.

PCS-Journey: Key Findings

As part of the PCS-Journey project, a systematic review and meta-analysis examined 94 international longitudinal studies involving more than 20,000 adults. The analysis focused on four particularly common and burdensome symptom domains: fatigue, shortness of breath, depressive symptoms and sleep problems. The project also investigated changes in health-related quality of life.

On average, all symptom domains investigated showed improvement. The most pronounced changes occurred within the first six months. In particular, between weeks 14 and 26, the prevalence of fatigue, shortness of breath, depressive symptoms and sleep problems decreased significantly. Symptom severity also declined, particularly during the first weeks and months.

However, an improvement in symptoms does not necessarily mean a full recovery. Fatigue, in particular, persisted beyond six months in a substantial proportion of those affected. The individual studies also revealed considerable differences in disease trajectories. While some people recover relatively quickly, others continue to experience symptoms over the long term.

“Our findings show a positive trend, but they do not tell the story of a uniform recovery. Average improvement should not be equated with full recovery. Fatigue, in particular, can persist over the long term in some affected individuals. For healthcare provision, this means that prognoses must be realistic, tailored to the individual and take long-term limitations into account,” says Dr Dominik Schröder.

Quality of Life Improves Despite Persistent Symptoms

Another important finding concerns health-related quality of life. It improved across all periods examined, even though some symptoms persisted. One possible explanation is that affected individuals develop coping strategies over time or adapt their daily routines to their condition. However, the available data do not allow researchers to determine conclusively whether these factors account for the improvement in quality of life.

“When assessing the course of the condition, a comprehensive perspective is essential. The key question is not simply whether a symptom is still present,” says Dr. Dominik Schröder. “Equally important are the ability to manage everyday life, independence, social participation and quality of life.”

These aspects were given particular consideration through the involvement of people with post-COVID in a public advisory board. Among other activities, participants helped select and prioritise relevant outcome measures and contributed to presenting the findings in an accessible way.

No Clear Prognostic Factors Identified

The findings were less conclusive regarding factors that might influence the subsequent course of the condition. The researchers investigated age, sex, pre-existing conditions and the severity of the initial COVID-19 illness, among other factors. However, differences in assessment methods and, in some cases, missing data meant that no single factor could be reliably identified as a decisive predictor of improvement, deterioration or persistent symptoms.

These findings highlight the need for high-quality longitudinal studies using comparable methods. Consistent definitions of post-COVID syndrome, validated assessment tools, clearly defined baseline time points and longer follow-up periods could help improve predictions of individual disease trajectories in the future.

Implications for Healthcare and Rehabilitation

The findings support an individually tailored approach to healthcare for people with post-COVID, including longer-term follow-up where necessary. Regular assessments should consider not only individual symptoms but also functional capacity, the ability to manage everyday activities and quality of life.

The findings also offer important insights for rehabilitation. Treatment success should not be assessed solely on the basis of whether symptoms have disappeared completely. Improvements in independence, social participation and quality of life can be equally important treatment goals.

PCS-Journey did not investigate the effectiveness of individual treatments. Its findings therefore do not support recommendations for any specific treatment. Instead, they provide important reference values for future intervention studies: when assessing whether an individual's condition improves over time, researchers must carefully distinguish any additional treatment-related improvement from the natural course of the condition.

“The findings from PCS-Journey demonstrate how important it is to assess Long COVID in terms of more than individual symptoms. Ultimately, what matters to those affected is whether they can manage everyday life again, live independently, return to work and participate in society,” says Sebastian Semler, LongCARE project lead and Executive Director of TMF e.V. “LongCARE provides a framework for bringing together scientific findings from different studies and projects and translating them into practice, with the perspectives of those affected at the centre.”

Press Contact

Isabel Merchan
Tel.: +49 30 2200 24769
Email: presse@tmf-ev.de

About the LongCARE Coordination Project

LongCARE encompasses 30 projects funded under the German Federal Ministry of Health’s Long COVID funding programme. Their aim is to investigate Long COVID and improve care for those affected. LongCARE provides a platform for knowledge transfer for both its own projects and projects funded through other programmes. LongCARE is coordinated by TMF – Technology, Methods, and Infrastructure for Networked Medical Research (TMF e.V.), in cooperation with the Network of University Medicine (NUM) and the Association of the Scientific Medical Societies in Germany (AWMF).